Ypsomed Holding AG

SWX:YPSN Stock Report

Market Cap: CHF 4.9b

Ypsomed Holding Valuation

Is YPSN undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Share Price vs Fair Value

What is the Fair Price of YPSN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Discounted Cash Flow
Simply Wall St
CHF 513.38
Fair Value
29.2% undervalued intrinsic discount
5
Number of Analysts

Key Valuation Metric

Which metric is best to use when looking at relative valuation for YPSN?

Key metric:

The above table shows the Price to Earnings ratio for YPSN. This is calculated by dividing YPSN's market cap by their current earnings.
What is YPSN's PE Ratio?
PE Ratio66.7x
EarningsCHF 74.39m
Market CapCHF 4.89b

Price to Earnings Ratio vs Peers

How does YPSN's PE Ratio compare to its peers?

The above table shows the PE ratio for YPSN vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Averagen/a

Price to Earnings Ratio vs Industry

How does YPSN's PE Ratio compare vs other companies in the Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No. of Companies0PE048121620
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price to Earnings Ratio vs Fair Ratio

What is YPSN's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

YPSN PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio66.7x
Fair PE Ratio55.5x

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Price Target
Consensus Narrative from 5 Analysts
CHF 415.60
Fair Value
12.5% undervalued intrinsic discount
5
Number of Analysts

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/22 04:23
End of Day Share Price 2025/01/22 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Ypsomed Holding AG is covered by 10 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Gaurav JainBarclays
Curtis MoilesBNP Paribas Exane
Thomas BernhardsgrutterCA Cheuvreux